Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Other possibilities that would cause trouble include extremely low vaccine uptake, or the avian influenza currently circulating in cows adapting to spread between people, Carlton said. RSV also ...

The new RSV vaccination programme launched earlier this wek will provide protection against the infection for the first time in Wales. Respiratory Syncytial Virus (RSV) is a contagious virus that ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research. Study: ...

The NHS in the South East is offering RSV vaccines to pregnant women and older adults Credit: ITV News Meridian NHS teams across the South East are gearing up to roll out RSV vaccinations for the ...

But that’s not a reason to skip the latest doses for COVID-19, influenza and respiratory syncytial virus. “Immunization lowers the chances of becoming ill, and, if you do get ill, reduces the ...

Midwives from North Cumbria Integrated Care NHS Foundation Trust are urging pregnant women to take up a new vaccine to protect their babies. The RSV (Respiratory Syncytial Virus) vaccine will be ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

Vaccination effectiveness did not differ with inverse probability of vaccination weighting or for those aged 60 to 74 years and 75 years and older. HealthDay News — For older adults, respiratory ...

The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are 75% less likely to be hospitalized from ...